VaxCare: An Easier way to Provide Long-Acting Reversible Contraceptives
While there are many contraceptive options available, long-acting reversible contraceptives (LARCs) are considered first-line due to greater than 99% efficacy, favorable safety profile, tolerability and extended duration of action (3 to 10 years). One challenge for ensuring timely administration of LARCs in the office is the high, up-front cost of stocking implants and IUDs.
Learn about how VaxCare and Partners For Kids are working to promote access to LARCs
Published May 2022